Clinical Trials in Maryland

Showing 5201-5220 of 23,284 trials

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

NCT05740293

The objective of the post-approval study (PAS) is to assess patient experience of visual symptoms 6 months after bilateral treatment with the VisuMax SMILE procedure as measured by a patient questionnaire.

MyopiaAstigmatism

Carl Zeiss Meditec, Inc.186 participantsStarted Apr 2022

Fayetteville, Arkansas, United States • Rowland Heights, California, United States • Leawood, Kansas, United States +4 more locations

TERMINATEDPhase 217 miles

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

NCT03501979

A phase 2 non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab with capecitabine for the treatment of leptomeningeal metastases in HER2-neu positive breast cancer.

Metastatic Breast CancerLeptomeningeal Disease

University of Alabama at Birmingham17 participantsStarted Feb 2019

Birmingham, Alabama, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +6 more locations

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Find Trials by Condition in Maryland

Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms

Mitral Valve Screening Survey

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Long-Term Evaluation of BIIB067 (Tofersen)

Sound and Music for Mild Cognitive Impairment

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy